Summary: The Sacramento Bee explores the potential psychedelic-assisted psychotherapy may have in treating mental health conditions resulting from the coronavirus pandemic. “To address the inevitable spike of mental illnesses, we must hasten the approval of new evidence-based medications for depression and PTSD. These include the psychedelic compounds MDMA and psilocybin,” says The Sacramento Bee.
Originally appearing here.